Learn how the entire cancer care team can help in promoting safe oral anti-cancer medication adherence by bridging gaps in patient education, management, and monitoring.
Find the CANCER BUZZ podcast on Apple Podcasts, Spotify, or wherever you get your podcasts!
Oral anti-cancer medications are one of the most important recent developments in oncology: less invasive than infusions, able to be taken at home, and offering more independence to patients. But if treatment isn’t coordinated properly, issues with safety and adherence can impact patient outcomes.
On this episode of CANCER BUZZ, learn how the entire cancer care team can help in promoting safe oral anti-cancer medication adherence by bridging gaps in patient education, management, and monitoring
Guest: Emily Hajjar, PharmD, MS, BCPS, BCACP, BCGP, Program Director, Population Health Pharmacy Program, Jefferson College of Pharmacy
Related Content:
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Cancer Care Centers.
July 8, 2026
June 30, 2026
At the 2026 ASCO Annual Meeting, the Louisiana Oncology Society received the ASCO Jeffrey C Ward Affiliate Advocacy Award for advancing critical advocacy priorities that have translated into meaningful legislative victories. The Iowa Oncology Society and Washington State Medical Oncology Society were also recognized for their advocacy efforts in 2025 at the meeting, receiving second place awards.
